An immunohistochemical and electron microscopic study of atypical teratoid/rhabdoid tumor. 2008

Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
Department of Neurosurgery, Kansai Medical University, 10-15 Fumizono, Moriguchi, Osaka 570-8507, Japan.

We report two infant cases with atypical teratoid/rhabdoid tumor (AT/RT) located in the cerebellar vermis and spinal cord. MRI showed the tumors were isointense on T1-weighted images and mixed intensity of isointense and slight high intensity on T2-weighted images. Postcontrast MRI demonstrated clear margin of tumor and heterogeneous strong enhancement. It was difficult to differentiate the tumor from medulloblastoma by hematoxylin and eosin staining. However, immunohistochemical staining showed that these tumor cells react positively for cytokeratin, smooth muscle actin (SMA), and epithelial membrane antigen (EMA) and helped us with the differentiation. Electron microscopic study has confirmed the presence of mesenchymal components, such as filaments and desmosome junctions in the rhabdoid cells, but no neuronal components. The tumors rapidly increased in size, showing high MIB-1 index, and the prognosis was gave.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D002528 Cerebellar Neoplasms Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141) Benign Cerebellar Neoplasms,Cerebellar Cancer,Malignant Cerebellar Neoplasms,Cerebellar Neoplasms, Benign,Cerebellar Neoplasms, Malignant,Cerebellar Neoplasms, Primary,Cerebellar Tumors,Neoplasms, Cerebellar,Neoplasms, Cerebellar, Benign,Neoplasms, Cerebellar, Malignant,Neoplasms, Cerebellar, Primary,Primary Neoplasms, Cerebellum,Benign Cerebellar Neoplasm,Cancer, Cerebellar,Cerebellar Cancers,Cerebellar Neoplasm,Cerebellar Neoplasm, Benign,Cerebellar Neoplasm, Malignant,Cerebellar Neoplasm, Primary,Cerebellar Tumor,Cerebellum Primary Neoplasm,Cerebellum Primary Neoplasms,Malignant Cerebellar Neoplasm,Neoplasm, Benign Cerebellar,Neoplasm, Cerebellar,Neoplasm, Cerebellum Primary,Neoplasm, Malignant Cerebellar,Primary Cerebellar Neoplasm,Primary Cerebellar Neoplasms,Primary Neoplasm, Cerebellum,Tumor, Cerebellar
D004396 Coloring Agents Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. Coloring Agent,Dye,Dyes,Organic Pigment,Stain,Stains,Tissue Stain,Tissue Stains,Organic Pigments,Pigments, Inorganic,Agent, Coloring,Inorganic Pigments,Pigment, Organic,Pigments, Organic,Stain, Tissue,Stains, Tissue
D004801 Eosine Yellowish-(YS) A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media. Eosin,Eosine Yellowish,Tetrabromofluorescein,Acid Red 87,C.I. Acid Red 87,Eosin (yellowish) (free acid),Eosin Y,Eosine,Eosine Yellowish-(YS), Dipotassium Salt,Eosine Yellowish-(YS), Potassium, Sodium Salt
D005260 Female Females

Related Publications

Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
February 2016, Neuropathology : official journal of the Japanese Society of Neuropathology,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
September 2016, Nihon rinsho. Japanese journal of clinical medicine,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
August 2006, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
October 2004, Neuroradiology,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
July 2017, Journal of neuroradiology = Journal de neuroradiologie,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
January 2010, Neurology India,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
January 2011, Journal of pediatric neurosciences,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
March 2000, Pediatric neurosurgery,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
January 2017, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society,
Toshitaka Seno, and Takuya Kawaguchi, and Takahiro Yamahara, and Yasuo Sakurai, and Tetsuya Oishi, and Takayuki Inagaki, and Yasuo Yamanouchi, and Akio Asai, and Keiji Kawamoto
January 2013, Turk patoloji dergisi,
Copied contents to your clipboard!